J 2019

Conservative vs liberal fluid therapy in septic shock (CLASSIC) trial-Protocol and statistical analysis plan

MEYHOFF, T.S., P.B. HJORTRUP, M.H. MOLLER, J. WETTERSLEV, T. LANGE et. al.

Základní údaje

Originální název

Conservative vs liberal fluid therapy in septic shock (CLASSIC) trial-Protocol and statistical analysis plan

Autoři

MEYHOFF, T.S. (garant), P.B. HJORTRUP, M.H. MOLLER, J. WETTERSLEV, T. LANGE, M.B.N KJR, A.B. JONSSON, C.J.S HJORTSO, M. CRONHJORT, J.H. LAAKE, S.M. JAKOB, M. NALOS, V. PETTIL, I. VAN DER HORST, M. OSTERMANN, P.. MOUNCEY, K. ROWAN, M. CECCONI, R. FERRER, M.L.N.G. MALBRAIN, C. AHLSTEDT, S. HOFFMANN, M.H. BESTLE, L. NEBRICH, L. RUSSELL, M. VANG, M.L. RASMUSSEN, C. SOLLING, B.S. RASMUSSEN, A.C. BROCHNER a A. PERNER

Vydání

Acta Anaesthesiologica Scandinavica, HOBOKEN, WILEY, 2019, 0001-5172

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30230 Other clinical medicine subjects

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 2.050

Kód RIV

RIV/00216224:14110/19:00124330

Organizační jednotka

Lékařská fakulta

UT WoS

000477274600001

Klíčová slova česky

INTENSIVE;CARESEPSIS;PROTOCOL; MISSING DATA; RESUSCITATION; MANAGEMENT; MORTALITY; VOLUMES; ADULTS

Klíčová slova anglicky

INTENSIVE;CARESEPSIS;PROTOCOL; MISSING DATA; RESUSCITATION; MANAGEMENT; MORTALITY; VOLUMES; ADULTS
Změněno: 17. 5. 2022 13:17, Mgr. Tereza Miškechová

Anotace

V originále

Introduction Intravenous (IV) fluid is a key intervention in the management of septic shock. The benefits and harms of lower versus higher fluid volumes are unknown and thus clinical equipoise exists. We describe the protocol and detailed statistical analysis plan for the conservative versus liberal approach to fluid therapy of septic shock in the Intensive Care (CLASSIC) trial. The aim of the CLASSIC trial is to assess benefits and harms of IV fluid restriction versus standard care in adult intensive care unit (ICU) patients with septic shock. Methods CLASSIC trial is an investigator-initiated, international, randomised, stratified, and analyst-blinded trial. We will allocate 1554 adult patients with septic shock, who are planned to be or are admitted to an ICU, to IV fluid restriction versus standard care. The primary outcome is mortality at day 90. Secondary outcomes are serious adverse events (SAEs), serious adverse reactions (SARs), days alive at day 90 without life support, days alive and out of the hospital at day 90 and mortality, health-related quality of life (HRQoL), and cognitive function at 1 year. We will conduct the statistical analyses according to a pre-defined statistical analysis plan, including three interim analyses. For the primary analysis, we will use logistic regression adjusted for the stratification variables comparing the two interventions in the intention-to-treat (ITT) population. Discussion The CLASSIC trial results will provide important evidence to guide clinicians' choice regarding the IV fluid therapy in adults with septic shock.

Návaznosti

90090, velká výzkumná infrastruktura
Název: CZECRIN II